Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1299 (LINC01299)

Target
LINC01299
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

Long intergenic non-protein coding RNA 1299 (LINC01299) is a long non-coding RNA (lncRNA) gene, annotated at least in the human genome (Ensembl ENSG00000254081, NCBI Gene 286186), and located on chromosome 8:65526738-65562781 (GRCh38)[1][3]. It is also referenced as CTD-3025N20.2 in the literature[1]. LINC01299 does not encode a protein, but acts as a regulatory RNA implicated in cellular processes such as cell proliferation and potentially in the regulation of gene expression[7]. There is little evidence in the literature of its direct involvement as a therapeutic target, and it is not currently classified as a receptor, enzyme, transporter, or conventional drug target. It has not been established as a clinically actionable biomarker, nor are there known drugs targeting it or associated safety considerations. The biological and clinical significance of LINC01299 remains under investigation[1][3][7][5]. **Notes:** - The source at MapMyGenome (learn.mapmygenome.in) places LINC01299 on chromosome 12, but authoritative databases (NCBI, Ensembl) and the GDC Data Portal agree on chromosome 8—chromosome 8:65526738-65562781 (GRCh38)[1][3]. The chromosome 12 location should be disregarded as an error. - No evidence surfaced that LINC01299 is considered a classic therapeutic target or is actionable in clinical contexts[1][3][7][5].

Other names
CTD-3025N20.2
02

Biological functions

Cell proliferationRegulation of gene expressionOther
03

Disease associations

Other (no strong evidence as a cancer driver or primary disease biomarker)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1299 (LINC01299).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1299 (LINC01299).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call